MASLD
-
healthThe Silent Threat: What Women Need to Know About Liver Disease
Liver disease affects millions of US adults, with women at higher risk. Understand causes, symptoms, and stages.
-
healthThe Silent Threat: Understanding Liver Disease in Women
Learn about chronic liver disease, its stages, symptoms, and causes, with a focus on risks for women.
-
healthKetogenic Diet Dramatically Slashes Liver Fat in MASLD Patients
A very low-energy ketogenic diet significantly reduced liver fat by 77% in MASLD patients, far surpassing a Mediterranean diet in a pilot study.
-
healthBinge Drinking Once Monthly Triples Liver Fibrosis Risk in MASLD Patients
New US study reveals that episodic heavy drinking significantly elevates liver fibrosis risk for individuals with metabolic dysfunction-associated steatotic liver disease.
-
healthMASLD Drives Rise in Cirrhosis Across Northern Mexico
Metabolic dysfunction-associated steatotic liver disease (MASLD) now leads chronic liver disease in northeastern Mexico, linked to rising obesity and diabetes.
-
healthObesity Drives Advanced Liver Disease-New Treatments Emerge
Obesity is now a leading cause of cirrhosis and liver cancer. Weight loss and GLP-1 drugs show promise in halting progression.
-
healthCBD and CBG Show Promise in Fighting Fatty Liver
New study reveals CBD and CBG improve liver function, reduce fat, and enhance metabolic health. Researchers highlight potential for plant-based treatments in MASLD.
-
healthFIB-4 Index Falls Short in Detecting Liver Fibrosis in MASLD Patients
A major primary care study finds the widely used FIB-4 screening tool unreliable for identifying liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease.